Home Top Movers Myovant Sciences Ltd. (MYOV) Stock Continues Uptrend Following Pipeline Candidate Development

Myovant Sciences Ltd. (MYOV) Stock Continues Uptrend Following Pipeline Candidate Development

Myovant Sciences Ltd. (MYOV) stock prices were up by 3.33% as of the market closing on May 21st, 2021, bringing the price per share up to USD$22.98 at the end of the trading day.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Launch of ORGVYX

ORGOVYX saw its launch in the United States commencing in early January of the fiscal year 2021, with authorized specialty distribution channels being fully restocked concurrently. Net product revenues generated from ORGGOVYX in the U.S. were reported at USD$3.6 million for the fourth quarter of the fiscal year 2020. As of April 30th 2021, more than 2000 patients had been prescribed ORGOVYX by over 800 various treatment centers.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

Increasing Coverage

April 30th, 2021 saw the company having achieved commercial coverage of 43%, as well as 51% Medicare Part D coverage for ORGOVYX. MYOV continuously seeks to engage with key commercial and Medicare Part D payors to negotiate coverage, in the interests of its goal of broad coverage by the end of the calendar year 2021.

MAA Validation by EMA

The company announced on March 29th, 2021 that the European Medicines Agency (EMA) had validated a previously submitted Marketing Authorization Application (MAA). The MAA was for MYOV’s flagship relugolixin regard to the treatment of advanced prostate cancer. The validation of the MAA consolidated the sufficient completion of the submission for the EMA to initiate the review process.

Strategic Partnership with Pfizer

March 24th, 2021 had seen MYOV and Pfizer collaboratively announce the positive safety and efficacy data from the Phase 3 LIBERTY randomized withdrawal study in women with uterine fibroids. The resounding success of the study was made apparent with the meeting of its primary endpoint, as well as all of its three key secondary endpoints. Furthermore, the incidence of adverse events over an addition year of treatment was consistent with prior observations, with no new safety signals being observed.

Revenue Breakdown

Revenues reported for the three-month period ended March 31st, 2021 were USD$24.6 million, while USD$59.3 million were reported for the fiscal year ended the same date. As the company’s initial reportings, there were no recorded revenues reported in the prior year periods. Of these totals, Product revenue accounted for USD$3.6 million for both the three months and the year ended March 31st, 2021. Collaboration revenue amounted to USD$21 million and USD$22.4 million for the three months and the year ended March 31st, 2021, respectively.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Future Outlook for MYOV

With the company indicating a promising end to the fiscal year 2020, it is poised to capitalize on the fiscal year 2021. With increasing coverage and strategic partnerships, MYOV is hopeful for the increased coverage and proliferation of relugolix and its other pipeline candidates. Current and potential investors are hopeful that MYOV will be able to leverage the resources at its disposal to usher in significant and sustained increases in shareholder value.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Aprea Therapeutics Inc. (APRE) stock soars during current market trading. What’s the update?

Aprea Therapeutics Inc. (NASDAQ: APRE) stock gained by 41.03% at the last check in the current market trading. Aprea Therapeutics is a pharmaceutical business...

Roblox Corp. (NASDAQ: RBLX) stock falls during pre-market trading session. What’s happening?

Roblox Corp. (NASDAQ: RBLX) stock gained by 2.28% at last close while the RBLX stock price declines by 8.13% in the pre-market trading session....

Can-Fite BioPharma Inc. (CANF) stock soars during current market. Why so?

Can-Fite BioPharma Inc. (NASDAQ: CANF) stock gained by 4.42% in the current market trading session. Can-Fite BioPharma Ltd. is a medication research company in...

UXIN stock surges during current market. Here’s to know why?

Uxin Ltd. (NASDAQ: UXIN) stock gains by 14.67% at last check during current market trading. In China, Uxin Limited is a prominent online used...

Opgen Inc. (OPGN) stock surged during pre-market session. What’s driving it high?

Opgen Inc. (NASDAQ: OPGN) stock declined by 1.84% at the last close whereas the OPGN stock price gains by 22.07% in the pre-market trading...

Aprea Therapeutics Inc. (APRE) stock soars during current market trading. What’s the update?

Aprea Therapeutics Inc. (NASDAQ: APRE) stock gained by 41.03% at the last check in the current market trading. Aprea Therapeutics is a pharmaceutical business...

TAL Education Group (TAL) stock is tumbling today: What’s Going on?

Shares of the TAL Education Group (TAL) stock were tumbling in the current market trading session today on June 16, 2021, without any obvious...

SPI Energy Inc. (SPI) stock surged in the current market trading. Here’s the update

SPI Energy Inc. (NASDAQ: SPI) stock soars by 15.42% during the current market trading session. SPI Energy is an international renewable energy company that...

Related News

Applied UV, Inc. (AUVI) stock is Popping High today: Here’s to know why

Applied UV, Inc. (AUVI) stock announced today that its SteriLumen Lumicide™ Ribbon which is its proprietary connected UVC disinfection platform for surface disinfection can...

TAL Education Group (TAL) stock is tumbling today: What’s Going on?

Shares of the TAL Education Group (TAL) stock were tumbling in the current market trading session today on June 16, 2021, without any obvious...

Why Kindred Biosciences, Inc. (KIN) stock is soaring today?

Shares of the Kindred Biosciences, Inc. (KIN) stock continuing the rising trend in pre-market today on June 16, 2021, following the announcement of the...

Ampio Pharmaceuticals Inc. (AMPE) stock fell during pre-market trading. Here’s to know why?

Ampio Pharmaceuticals Inc. (NASDAQ: AMPE) stock gained by 4.71% at last close whereas the AMPE stock price declines by 2.65% in the pre-market trading...

Aptinyx Inc. (APTX) stock fell during after-hour. Here’s to know why?

Aptinyx Inc. (NASDAQ: APTX) stock declined by 0.29% at last close while the APTX stock price has been observed falling more during the after-hour...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam